DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,863,895 | 0.0% | 507,766 | 0.0% | 2.56% | 0.0% |
| Q2 2023 | $121,863,895 | -1.2% | 507,766 | +3.8% | 2.56% | -12.9% |
| Q1 2023 | $123,318,205 | -4.4% | 489,280 | +0.7% | 2.94% | -9.0% |
| Q4 2022 | $128,965,050 | +2.3% | 485,890 | -0.5% | 3.23% | -7.3% |
| Q3 2022 | $126,079,000 | +1.5% | 488,130 | -0.4% | 3.49% | +8.8% |
| Q2 2022 | $124,248,000 | -16.3% | 490,090 | -3.2% | 3.20% | +1.0% |
| Q1 2022 | $148,462,000 | -11.9% | 506,127 | -1.2% | 3.17% | -9.2% |
| Q4 2021 | $168,504,000 | +7.6% | 512,155 | -0.4% | 3.49% | -5.0% |
| Q3 2021 | $156,542,000 | +12.3% | 514,198 | -1.0% | 3.68% | +12.9% |
| Q2 2021 | $139,350,000 | +18.8% | 519,264 | -0.4% | 3.26% | +9.7% |
| Q1 2021 | $117,329,000 | +0.8% | 521,275 | -0.6% | 2.97% | -3.3% |
| Q4 2020 | $116,442,000 | -1.8% | 524,185 | -4.8% | 3.07% | -11.5% |
| Q3 2020 | $118,534,000 | +51.5% | 550,477 | -2.6% | 3.47% | +10.8% |
| Q1 2020 | $78,252,000 | -11.3% | 565,366 | -1.6% | 3.13% | +15.1% |
| Q4 2019 | $88,183,000 | +6.6% | 574,555 | +0.3% | 2.72% | -1.4% |
| Q3 2019 | $82,715,000 | -6.1% | 572,701 | -7.1% | 2.76% | -5.3% |
| Q2 2019 | $88,109,000 | +5.6% | 616,494 | -2.5% | 2.92% | +0.2% |
| Q1 2019 | $83,439,000 | +27.4% | 632,017 | -0.5% | 2.91% | +10.1% |
| Q4 2018 | $65,482,000 | -7.1% | 635,008 | -2.1% | 2.64% | +10.5% |
| Q3 2018 | $70,514,000 | +9.5% | 648,944 | -0.6% | 2.39% | +3.8% |
| Q2 2018 | $64,412,000 | +50.8% | 652,736 | +49.6% | 2.31% | +42.3% |
| Q1 2018 | $42,713,000 | +3.3% | 436,245 | -2.1% | 1.62% | +8.1% |
| Q4 2017 | $41,361,000 | +8.3% | 445,604 | +0.1% | 1.50% | +3.1% |
| Q3 2017 | $38,187,000 | +3.6% | 445,169 | +1.9% | 1.46% | -1.3% |
| Q2 2017 | $36,866,000 | +4.7% | 436,850 | +6.1% | 1.47% | +3.7% |
| Q1 2017 | $35,209,000 | +8.9% | 411,653 | -0.9% | 1.42% | +3.6% |
| Q4 2016 | $32,327,000 | +1.6% | 415,299 | +2.3% | 1.37% | -1.6% |
| Q3 2016 | $31,824,000 | -21.8% | 405,972 | +0.7% | 1.39% | -23.6% |
| Q2 2016 | $40,702,000 | +5.9% | 402,991 | -0.5% | 1.82% | +2.2% |
| Q1 2016 | $38,429,000 | +2.8% | 405,116 | +0.7% | 1.78% | +4.3% |
| Q4 2015 | $37,367,000 | +11.9% | 402,315 | +2.6% | 1.71% | +3.9% |
| Q3 2015 | $33,401,000 | +3.5% | 391,983 | +4.0% | 1.65% | +11.9% |
| Q2 2015 | $32,258,000 | +19.6% | 376,887 | +18.7% | 1.47% | +19.7% |
| Q1 2015 | $26,961,000 | +3.6% | 317,567 | +4.5% | 1.23% | +0.2% |
| Q4 2014 | $26,035,000 | +15.9% | 303,762 | +2.8% | 1.23% | +14.9% |
| Q3 2014 | $22,455,000 | +12.3% | 295,538 | +16.4% | 1.07% | +9.5% |
| Q2 2014 | $19,991,000 | +16.7% | 253,919 | +11.1% | 0.97% | +9.6% |
| Q1 2014 | $17,137,000 | +33.5% | 228,489 | +37.5% | 0.89% | +30.4% |
| Q4 2013 | $12,833,000 | +12.1% | 166,224 | +0.6% | 0.68% | +2.1% |
| Q3 2013 | $11,449,000 | +10.5% | 165,158 | +0.9% | 0.67% | +4.4% |
| Q2 2013 | $10,359,000 | – | 163,647 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |